Nayak Sanjay
Chief Strategy Officer
Nayak Sanjay has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.
On the most recent filing, Nayak Sanjay is listed as Chief Strategy Officer at OCULAR THERAPEUTIX, INC. Inside the rolling window, Nayak Sanjay reported no open-market purchases and 5 open-market sales totaling $166K in OCUL. The largest disclosed transaction in the window is a sale of 10,348 OCUL shares on Feb 12, 2026, worth $94K.
Companies traded
Other insiders at OCUL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$166K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nayak Sanjay made?
Nayak Sanjay has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Nayak Sanjay trade?
Nayak Sanjay has filed SEC Form 4 disclosures for 1 company, including OCUL.
When was Nayak Sanjay's most recent SEC Form 4 filing?
Nayak Sanjay's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.
What is Nayak Sanjay's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nayak Sanjay is listed as Chief Strategy Officer.
What is Nayak Sanjay's total buy and sell value in the current window?
Inside the rolling retention window, Nayak Sanjay bought $0 and sold $166K based on SEC Form 4 filings.
What was Nayak Sanjay's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,348 OCUL shares on 2026-02-12, worth $94K, per SEC Form 4 filings.